Respiratory disorders
17 results
Applied filters
SMRs in problematic polypharmacy: respiratory focus
13 January 2026Consultant pharmacists used a case study to illustrate a patient centred approach to SMRs for patients with respiratory conditions.
The licence and supporting evidence for omalizumab biosimilar
20 April 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. Review its indications, evidence, and main differences.
Preparing to use omalizumab biosimilar
20 April 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. We offer general information and implementation advice.
Clarithromycin for sinusitis
18 March 2026SPS PGD template for the supply of clarithromycin for sinusitis in penicillin allergy and where an intranasal steroid is unsuitable or ineffective.
Clarithromycin for otitis media
28 May 2026SPS PGD template for the supply of clarithromycin for otitis media in those with a penicillin allergy.
Fluticasone furoate nasal spray for sinusitis
25 March 2026SPS PGD template for the supply of fluticasone furoate nasal spray for sinusitis.
Otigo (phenazone with lidocaine) ear drops for otitis media
3 June 2026SPS PGD template for the supply of Otigo (phenazone with lidocaine) ear drops for symptomatic relief of pain due to otitis media.
Penicillin V (phenoxymethylpenicillin) for sinusitis
18 March 2026SPS PGD template for the supply of penicillin V (phenoxymethylpenicillin) where an intranasal steroid is unsuitable or ineffective.
Amoxicillin for otitis media
28 May 2026SPS PGD template for the supply of amoxicillin for otitis media.
Erythromycin for sore throat
21 April 2026SPS PGD template for the supply of erythromycin for sore throat in both penicillin allergy and pregnancy.